Strategies for Infection Control and Prevalence of Anti-SARS-CoV-2 IgG Antibodies in 4,554 Employees of a University Hospital in Munich, Germany. Preprint
GHDx Entry last modified on: Mar 14, 2022
Data by Data Type
Spain Prevalence of Depression, Before and After the Covid-19 Pandemic 2020
GHDx Entry last modified on: Oct 10, 2022
SARS-CoV-2 Seroprevalence Survey Estimates Are Affected by Anti-Nucleocapsid Antibody Decline
GHDx Entry last modified on: May 12, 2022
Seroprevalence of Antibodies to SARS-CoV-2 in 10 Sites in the United States, March 23-May 12, 2020
GHDx Entry last modified on: May 12, 2022
Severe Acute Respiratory Syndrome Coronavirus 2 Seroprevalence Among Adults in a Tropical City of the Caribbean Area, Colombia: Are We Much Closer to Herd Immunity Than Developed Countries?
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 IgG seroprevalence in blood donors located in three different federal states, Germany, March to June 2020
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 transmission among children and staff in daycare centres during a nationwide lockdown in France: a cross-sectional, multicentre, seroprevalence study
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 infection in primary schools in northern France: A retrospective cohort study in an area of high transmission. Preprint
GHDx Entry last modified on: Jun 17, 2021
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Universal Testing Experience on a Los Angeles Labor and Delivery Unit
GHDx Entry last modified on: Jan 31, 2024
Sentinel seroprevalence of SARS-CoV-2 in the Gauteng province, South Africa August to October 2020. Preprint
GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 seroprevalence study in Lambayeque, Peru. June-July 2020
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of Anti-SARS-CoV-2 Antibodies in Blood Donors from Nuevo Leon State, Mexico, during 2020: A Retrospective Cross-Sectional Evaluation
GHDx Entry last modified on: Jan 31, 2024
SARS-COV-2 antibody seroprevalence in the general population of Oman: results from four successive nationwide seroepidemiological surveys
GHDx Entry last modified on: May 12, 2022
Sociodemographic Predictors of SARS-CoV-2 Infection in Obstetric Patients, Georgia, USA
GHDx Entry last modified on: Apr 10, 2023
Seroprevalence of VZV and HSV-2 Antibodies among Women of Childbearing Age Referring to Health Centres of Mashhad, Iran: The Need for Consideration of VZV Vaccination Program
GHDx Entry last modified on: May 23, 2024
Seroprevalence of immunoglobulin M and G antibodies against SARS-CoV-2 in China
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 antibody seroprevalence in Tbilisi, the capital city of country of Georgia. Preprint
GHDx Entry last modified on: Jun 17, 2021
SARS-CoV-2 seroprevalence among blood donors after the first COVID-19 wave in Canada
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 antibody seroprevalence follow-up in Malagasy blood donors during the 2020 COVID-19 Epidemic
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 total antibody is higher in younger Austrian blood donors
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 antibody seroprevalence and associated risk factors in an urban district of Cameroon. Preprint
GHDx Entry last modified on: May 12, 2022
SARS-CoV-2 Infection Is Asymptomatic in Nearly Half of Adults with Robust Anti-Spike Protein Receptor-Binding Domain Antibody Response
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of ancestral and Beta SARS-CoV-2 antibodies in Malagasy blood donors
GHDx Entry last modified on: May 12, 2022
Screening of severe acute respiratory syndrome coronavirus-2 infection during labor and delivery using polymerase chain reaction and immunoglobulin testing
GHDx Entry last modified on: Apr 10, 2023
Symptoms and quality of life at 1-year follow up of patients discharged after an acute COVID-19 episode
GHDx Entry last modified on: Mar 22, 2024
Seroprevalence of anti-SARS-CoV-2 IgG antibodies in Geneva, Switzerland (SEROCoV-POP): a population-based study
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 IgG antibodies in two regions of Estonia (KoroSero-EST-1)
GHDx Entry last modified on: Jun 17, 2021
Surveillance and Seroprevalence: Evaluation of IgG antibodies for SARS-Cov2 by ELISA in the popular neighborhood Villa Azul, Quilmes, province of Buenos Aires, Argentina. Preprint
GHDx Entry last modified on: Mar 14, 2022
Sero-Prevalence of SARS-CoV-2 Antibodies in High-Risk Populations in Vietnam
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies in Indore, Madhya Pradesh: A community-based cross-sectional study, August 2020
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study
GHDx Entry last modified on: Mar 14, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies in COVID-19 patients and healthy volunteers up to 6 months post disease onset
GHDx Entry last modified on: Mar 14, 2022
Safe Perinatal Management of Neonates Born to SARS-CoV-2 Positive Mothers at the Epicenter of the Italian Epidemic
GHDx Entry last modified on: Apr 10, 2023
Severe Fatigue in the First Year Following SARS-CoV-2 Infection: A Prospective Cohort Study
GHDx Entry last modified on: Mar 22, 2024
Sex differences in clinical characteristics of migraine and its burden: a population-based study
GHDx Entry last modified on: Mar 22, 2024
School bullying associated suicidal risk in children and adolescents from Yunnan, China: The mediation of social support
GHDx Entry last modified on: Mar 22, 2024
SARS-CoV-2 Antibody Seroprevalence in Industry Workers in Split-Dalmatia and Šibenik-Knin County, Croatia
GHDx Entry last modified on: Mar 14, 2022
Symptoms and Critical Illness Among Obstetric Patients With Coronavirus Disease 2019 (COVID-19) Infection
GHDx Entry last modified on: Jan 31, 2024
SARS-CoV-2 antibody seroprevalence in India, August-September, 2020: findings from the second nationwide household serosurvey
GHDx Entry last modified on: May 12, 2022
Seroprevalence of SARS-CoV-2 antibodies in Saint Petersburg, Russia: a population-based study. Preprint
GHDx Entry last modified on: Sep 21, 2021
SARS-CoV-2 IgG Antibodies Seroprevalence and Sera Neutralizing Activity in MEXICO: A National Cross-Sectional Study during 2020
GHDx Entry last modified on: May 12, 2022
SARS-CoV-2-Specific Antibody Prevalence and Symptoms in a Local Austrian Population
GHDx Entry last modified on: Mar 14, 2022
SARS-CoV-2 Seroprevalence in Aden, Yemen a Population-Based Study. Preprint
GHDx Entry last modified on: May 12, 2022
Seroprevalence of anti-SARS-CoV-2 antibodies in residents of Karachi-challenges in acquiring herd immunity for COVID 19
GHDx Entry last modified on: Jan 31, 2024
Systematic screening for SARS-CoV-2 in pregnant women admitted for delivery in a Portuguese maternity
GHDx Entry last modified on: Apr 10, 2023
Symptom Burden among Older COVID-19 Survivors Two Years after Hospital Discharge
GHDx Entry last modified on: Mar 22, 2024
Surveillance and epidemiological characterization of human adenovirus infections among outpatient children with acute gastroenteritis during the COVID-19 epidemic in Shanghai, China
GHDx Entry last modified on: Oct 23, 2024
Seroprevalence of IgG antibodies against SARS coronavirus 2 in Belgium - a serial prospective cross-sectional nationwide study of residual samples. Preprint
Cross-sectional
Screening all pregnant women admitted to labor and delivery for the virus responsible for coronavirus disease 2019
GHDx Entry last modified on: Jan 31, 2024
Seroprevalence of SARS-CoV-2 in slums versus non-slums in Mumbai, India
GHDx Entry last modified on: Jan 31, 2024
Pages
Subscribe
